Lungs

Results showed a 32 percent lower chance of cancer recurrence, progression, or death with immunotherapy plus chemotherapy versus chemotherapy alone

Translational findings and higher major pathological response support combinations over monotherapy before surgery

Tedopi® safely improved overall survival and quality of life in patients with hard-to-treat non-small cell lung cancer

Phase 3 trial establishes safety and overall survival rate of treatment with atezolizumab for non-small cell lung cancer

Mini-lung buds can be cultured and employed for high-throughput analysis of lung tissue infection without interfering variables

This document updates the previous guide with the latest recommendations regarding new tools for diagnosis

Analyzing the genetic code will yield a better understanding of tuberculosis and lead to better treatments

Less frequent CT scans after lung cancer surgery may reduce health-care costs, patient anxiety

Current findings support an increase of tobacco control efforts for countering viral infection